{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,4,23]],"date-time":"2024-04-23T23:26:21Z","timestamp":1713914781966},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,1,28]],"date-time":"2015-01-28T00:00:00Z","timestamp":1422403200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Endocr Disord"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1186\/1472-6823-15-4","type":"journal-article","created":{"date-parts":[[2015,6,18]],"date-time":"2015-06-18T07:46:31Z","timestamp":1434613591000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Transient hypercortisolism and symptomatic hyperthyroidism associated to primary hyperparathyroidism in an elderly patient: case report and literature review"],"prefix":"10.1186","volume":"15","author":[{"given":"Chiara","family":"Sabbadin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabriella","family":"Don\u00e0","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luciana","family":"Bordin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maurizio","family":"Iacobone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valentina","family":"Camozzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caterina","family":"Mian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Decio","family":"Armanini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,1,28]]},"reference":[{"key":"314_CR1","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1016\/j.maturitas.2011.07.021","volume":"70","author":"R Pyram","year":"2011","unstructured":"Pyram R, Mahajan G, Gliwa A: Primary hyperparathyroidism: skeletal and non-skeletal effects, diagnosis and management.Maturitas 2011, 70:246\u201355. 10.1016\/j.maturitas.2011.07.021","journal-title":"Maturitas"},{"key":"314_CR2","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1093\/ageing\/afg122","volume":"32","author":"S Conroy","year":"2003","unstructured":"Conroy S, Moulias S, Wassif WS: Primary hyperparathyroidism in the older person.Age Ageing 2003, 32:571\u20138. 10.1093\/ageing\/afg122","journal-title":"Age Ageing"},{"issue":"Suppl 3","key":"314_CR3","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.ctrv.2005.09.004","volume":"31","author":"MR Smith","year":"2005","unstructured":"Smith MR: Zoledronic acid to prevent skeletal complications in cancer: corroborating the evidence.Cancer Treat Rev 2005,31(Suppl 3):19\u201325.","journal-title":"Cancer Treat Rev"},{"key":"314_CR4","first-page":"35","volume":"70","author":"L Jacobs","year":"2012","unstructured":"Jacobs L, Samson MM, Verhaar HJ, Koek HL: Therapeutic challenges in elderly patients with symptomatic hypercalcaemia caused by primary hyperparathyroidism.Neth J Med 2012, 70:35\u20138.","journal-title":"Neth J Med"},{"key":"314_CR5","first-page":"598","volume":"85","author":"O Jannasch","year":"2013","unstructured":"Jannasch O, Voigt C, Reschke K, Lippert H, Mroczkowski P: Comparison of outcome between older and younger patients following surgery for primary hyperparathyroidism.Pol Przegl Chir 2013, 85:598\u2013604.","journal-title":"Pol Przegl Chir"},{"key":"314_CR6","first-page":"CS41","volume":"15","author":"G Rudofsky Jr","year":"2009","unstructured":"Rudofsky G Jr, Grafe IA, Metzner C, Leowardi C, Fohr B: Transient post-operative thyrotoxicosis after parathyroidectomy.Med Sci Monit 2009, 15:CS41\u20133.","journal-title":"Med Sci Monit"},{"key":"314_CR7","first-page":"224","volume":"75","author":"PG Walfish","year":"1992","unstructured":"Walfish PG, Caplan D, Rosen B: Postparathyroidectomy transient thyrotoxicosis.J Clin Endocrinol Metab 1992, 75:224\u20137.","journal-title":"J Clin Endocrinol Metab"},{"key":"314_CR8","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1007\/s004230050245","volume":"384","author":"P Lindblom","year":"1999","unstructured":"Lindblom P, Valdemarsson S, Westerdahl J, Tennval J, Bergenfelz A: Hyperthyroidism after surgery for primary hyperparathyroidism.Langenbeck\u2019s Arch Surg 1999, 384:568\u201375. 10.1007\/s004230050245","journal-title":"Langenbeck\u2019s Arch Surg"},{"key":"314_CR9","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1089\/thy.2010.0300","volume":"21","author":"L Calvi","year":"2011","unstructured":"Calvi L, Daniels GH: Acute thyrotoxicosis secondary to destructive thyroiditis associated with cardiac catheterization contrast dye.Thyroid 2011, 21:443\u20139. 10.1089\/thy.2010.0300","journal-title":"Thyroid"},{"key":"314_CR10","doi-asserted-by":"publisher","first-page":"456","DOI":"10.4158\/EP.17.3.456","volume":"17","author":"RS Bahn","year":"2011","unstructured":"Bahn RS, Burch HB, Cooper DS, Garber JR, Greenlee MC, Klein I, et al.: Hyperthyroidism and other causes of thyrotoxicosis: management guidelines of the American Thyroid Association and American Association of Clinical Endocrinologists.Endocr Pract 2011, 17:456\u2013520. Erratum in: Endocr Pract. 2013;19:384 10.4158\/EP.17.3.456","journal-title":"Endocr Pract"},{"key":"314_CR11","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1530\/eje.0.1400264","volume":"140","author":"G Hintze","year":"1999","unstructured":"Hintze G, Blombach O, Fink H, Burkhardt U, Kobberling J: Risk of iodine-induced thyrotoxicosis after coronary angiography: an investigation in 788 unselected subjects.Eur J Endocrinol 1999, 140:264\u20137. 10.1530\/eje.0.1400264","journal-title":"Eur J Endocrinol"},{"key":"314_CR12","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1111\/j.1365-2265.2010.03958.x","volume":"75","author":"N Yu","year":"2011","unstructured":"Yu N, Donnan PT, Leese GP: A record linkage study outcomes in patients with mild primary hyperparathyroidism: The Parathyroid Epidemiology and Audit Research Study (PEARS).Clin Endocrinol (Oxf) 2011, 75:169\u201376. 10.1111\/j.1365-2265.2010.03958.x","journal-title":"Clin Endocrinol (Oxf)"},{"key":"314_CR13","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1093\/eurheartj\/ehq109","volume":"31","author":"S Pilz","year":"2010","unstructured":"Pilz S, Tomaschitz A, Drechsler C, Ritz E, Boehm BO, Grammer TB, et al.: Parathyroid hormone level is associated with mortality and cardiovascular events in patients undergoing coronary angiography.Eur Heart J 2010, 31:1591\u20138. 10.1093\/eurheartj\/ehq109","journal-title":"Eur Heart J"},{"key":"314_CR14","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1161\/CIRCULATIONAHA.111.081307","volume":"126","author":"E Osto","year":"2012","unstructured":"Osto E, Fallo F, Pelizzo MR, Maddalozzo A, Sorgato N, Corbetti F, et al.: Coronary microvascular dysfunction induced by primary hyperparathyroidism is restored after parathyroidectomy.Circulation 2012, 126:1031\u20139. 10.1161\/CIRCULATIONAHA.111.081307","journal-title":"Circulation"},{"key":"314_CR15","first-page":"665","volume":"36","author":"C Sabbadin","year":"2013","unstructured":"Sabbadin C, Cavedon E, Zanon M, Iacobone M, Armanini D: Resolution of hypertension and secondary aldosteronism after surgical treatment of primary hyperaldosteronism.J Endocrinol Invest 2013, 36:665\u20136.","journal-title":"J Endocrinol Invest"},{"key":"314_CR16","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1007\/s00223-009-9245-7","volume":"84","author":"L Gianotti","year":"2009","unstructured":"Gianotti L, Tassone F, Pia A, Bovio S, Reimondo G, Visconti G, et al.: May an altered hypotalamo-pituitary-adrenal axis contribute to cortical bone damage in primary hyperparathyroidism?Calcif Tissue Int 2009, 84:425\u20139. 10.1007\/s00223-009-9245-7","journal-title":"Calcif Tissue Int"},{"key":"314_CR17","doi-asserted-by":"crossref","first-page":"E209","DOI":"10.1152\/ajpendo.2001.280.2.E209","volume":"280","author":"G Mazzocchi","year":"2001","unstructured":"Mazzocchi G, Aragona F, Malendowicz LK, Nussdorfer GG: PTH and PTH-related peptide enhance steroid secretion from human adrenocortical cells.Am J Physiol Endocrinol Metab 2001, 280:E209\u201313.","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"314_CR18","first-page":"932","volume":"81","author":"GE-H Fuleihan","year":"1996","unstructured":"Fuleihan GE-H, Brown EM, Gleason R, Scott J, Adler GK: Calcium modulation of adrenocorticotropin levels in women \u2013 a clinical research study.J Clin Endocrinol Metab 1996, 81:932\u20136.","journal-title":"J Clin Endocrinol Metab"},{"key":"314_CR19","first-page":"418","volume":"130","author":"R Rajput","year":"2009","unstructured":"Rajput R, Bhansali A, Bhadada SK, Behera A, Mittal BR, Sialy R, et al.: A pilot study on hypothalamo-pituitary-adrenocortical axis in primary hyperparathyroidism.Indian J Med Res 2009, 130:418\u201322.","journal-title":"Indian J Med Res"},{"key":"314_CR20","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1016\/0960-0760(94)90289-5","volume":"49","author":"D Armanini","year":"1994","unstructured":"Armanini D: Corticosteroid receptors in lymphocytes: a possible marker of brain involution?J Steroid Biochem Mol Biol 1994, 49:429\u201334. 10.1016\/0960-0760(94)90289-5","journal-title":"J Steroid Biochem Mol Biol"},{"key":"314_CR21","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.exger.2010.08.023","volume":"46","author":"G Aguilera","year":"2011","unstructured":"Aguilera G: HPA axis responsiveness to stress: implications for healthy aging.Exp Gerontol 2011, 46:90\u20135. 10.1016\/j.exger.2010.08.023","journal-title":"Exp Gerontol"},{"key":"314_CR22","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1007\/s12020-013-0112-y","volume":"46","author":"G Tirabassi","year":"2014","unstructured":"Tirabassi G, Boscaro M, Arnaldi G: Harmful effects of functional hypercortisolism: a working hypothesis.Endocrine 2014, 46:370\u201386. 10.1007\/s12020-013-0112-y","journal-title":"Endocrine"}],"container-title":["BMC Endocrine Disorders"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1472-6823-15-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1472-6823-15-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1472-6823-15-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,1,22]],"date-time":"2019-01-22T17:10:52Z","timestamp":1548177052000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcendocrdisord.biomedcentral.com\/articles\/10.1186\/1472-6823-15-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,1,28]]},"references-count":22,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["314"],"URL":"https:\/\/doi.org\/10.1186\/1472-6823-15-4","relation":{},"ISSN":["1472-6823"],"issn-type":[{"value":"1472-6823","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,1,28]]},"assertion":[{"value":"13 August 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 January 2015","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 January 2015","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"4"}}